EOLS compared with VYNE: revenue, margins and what each company keeps, and the suppliers and customers both name

EOLSEvolus, Inc.

Mkt capRevenueRevenue

VYNEVYNE Therapeutics Inc.

Mkt capRevenueRevenue

Compare

EOLSEvolus, Inc.

VYNEVYNE Therapeutics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

EOLS, solidVYNE, dashed

Supply-chain overlap

Revenue flow

EOLS: latest quarter is a loss; flow not drawable. VYNE revenue flow unavailable.Method ›

EOLSEvolus, Inc.

7.17▼−2.45%· post 7.17

Mkt cap$472.9MRevenue$84MQ2 FY26Revenue$297MFY25

VYNEVYNE Therapeutics Inc.

17.86▼−10.24%· post 17.86

ClosedNov 2 '26

Mkt cap—Revenue—Revenue—

Compare

ClosedNov 2 '26

EOLSEvolus, Inc.

VYNEVYNE Therapeutics Inc.

7.17▼−2.45%post 7.17

Price

17.86▼−10.24%post 17.86

$472.9M

Mkt cap

—

Q2 FY26$84M

Revenue

—

FY25$297M

Revenue

—

EOLS7.17▼−2.45%vsVYNE17.86▼−10.24%ClosedNov 2 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only EOLS 3

—Daewoong Pharmaceuticalsunlistedsupplier

—Symateseunlistedsupplier

—Symatese Aesthetics S.A.Sunlistedsupplier

Shared 0

No disclosed counterparties: VYNE.

Only VYNE 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR